Literature DB >> 15713146

Outcome of fertility-preserving treatment in young women with endometrial carcinomas.

K Niwa1, K Tagami, Z Lian, K Onogi, H Mori, T Tamaya.   

Abstract

OBJECTIVE: To evaluate the outcome of conservative treatment of young women with endometrial cancer.
DESIGN: Observational study.
SETTING: Gifu University Hospital, Japan from 1988 to 2002. POPULATION: Twelve women with endometrial cancer, FIGO IA estimated by MRI under 35 years.
METHODS: Patients were treated with medroxyprogestreone acetate (400-600 mg/day) for 6-10 months, with endometrial curettage performed every four weeks. MAIN OUTCOME MEASURES: Response to therapy, pregnancies and reoccurrence of disease during follow up over a 30-month period.
RESULTS: All cases had pathological complete remissions within 6-10 months. Seven of 10 wishing to have babies conceived, and five of them were delivered of full-term babies. Eight of nine cases receiving long term follow up (over 30 months) developed recurrent disease, with four opting for hysterectomy. No patient developed distant metastases or had disease-related death.
CONCLUSION: Conservative therapy is feasible in carefully selected young women with endometrial cancer. Recurrence rates were high during long term observation even after pathological complete remissions. Therefore, close follow up is recommended.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713146     DOI: 10.1111/j.1471-0528.2004.00398.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  26 in total

1.  Ovarian Stimulation Is Safe and Effective for Patients with Gynecologic Cancer.

Authors:  Ruba A Akel; Xiaoyue M Guo; Molly B Moravek; Rafael Confino; Kristin N Smith; Angela K Lawson; Susan C Klock; Edward J Tanner Iii; Mary Ellen Pavone
Journal:  J Adolesc Young Adult Oncol       Date:  2020-01-10       Impact factor: 2.223

Review 2.  Contemporary quality of life issues affecting gynecologic cancer survivors.

Authors:  Jeanne Carter; Richard Penson; Richard Barakat; Lari Wenzel
Journal:  Hematol Oncol Clin North Am       Date:  2011-12-16       Impact factor: 3.722

3.  Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development.

Authors:  Omar Habeeb; Lee Goodglick; Robert A Soslow; Rajiv G Rao; Lynn K Gordon; Osvaldo Schirripa; Steve Horvath; Jonathan Braun; David B Seligson; Madhuri Wadehra
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

4.  Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study.

Authors:  Richard J Zaino; William E Brady; William Todd; Kimberly Leslie; Edgar G Fischer; Neil S Horowitz; Robert S Mannel; Joan L Walker; Marina Ivanovic; Linda R Duska
Journal:  Int J Gynecol Pathol       Date:  2014-11       Impact factor: 2.762

Review 5.  Fertility preserving options in patients with gynecologic malignancies.

Authors:  Ramez N Eskander; Leslie M Randall; Michael L Berman; Krishnansu S Tewari; Philip J Disaia; Robert E Bristow
Journal:  Am J Obstet Gynecol       Date:  2011-03-16       Impact factor: 8.661

6.  Endometrial cancer arising from atypical complex hyperplasia: The significance in an endometrial biopsy and a diagnostic challenge.

Authors:  Jung Mi Byun; Dae Hoon Jeong; Young Nam Kim; En Bee Cho; Ju Eun Cha; Moon Su Sung; Kyung Bok Lee; Ki Tae Kim
Journal:  Obstet Gynecol Sci       Date:  2015-11-16

7.  Fertility-sparing treatment using medroxyprogesterone acetate for endometrial carcinoma.

Authors:  Hiroyuki Fujiwara; Toshiko Jobo; Yuji Takei; Yasushi Saga; Manami Imai; Tsutomu Arai; Akiyo Taneichi; Shizuo Machida; Yoshifumi Takahashi; Mitsuaki Suzuki
Journal:  Oncol Lett       Date:  2012-02-10       Impact factor: 2.967

8.  Response-specific progestin resistance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long-term exposure to medroxyprogesterone acetate.

Authors:  Shunjun Zhao; Genxia Li; Li Yang; Lei Li; Hongyu Li
Journal:  Oncol Lett       Date:  2012-10-17       Impact factor: 2.967

9.  Endometrial carcinoma in a young subfertile woman with polycystic ovarian syndrome.

Authors:  K Jayakrishnan; R Anupama; Aby Koshy; R Raju
Journal:  J Hum Reprod Sci       Date:  2010-01

10.  Controversies in the management of endometrial carcinoma.

Authors:  Ying Zhang; Jian Wang
Journal:  Obstet Gynecol Int       Date:  2010-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.